Trademark Overview
On Tuesday, September 30, 2025, a trademark application was filed for VASCVERSA with the United States Patent and Trademark Office. The USPTO has given the VASCVERSA trademark a serial number of 79436736. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Thursday, November 13, 2025. This trademark is owned by VASCVERSA LIMITED. The VASCVERSA trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Stem cells for research purposes; stem cells for scientific purposes; chemicals for use in manufacturing pharmaceuticals; reagents for research purposes; reagents for medical research; reagents for scientific purposes; diagnostic reagents for scientific or research use; cell culture reagents for scientific and research use; blood culture media for scientific use.
Medical and pharmacological research services; stem cell research; scientific services relating to the isolation and cultivation of human tissues and cells; research in the field of cell engineering technology; research in the field of vascular regeneration and repair; research and development of medicines; pharmaceutical drug development services; drug discovery services; development of pharmaceutical preparations and medicines; development of cell therapies; research and development services in the medical field of cell therapy; research and development services in the medical field of vascular regeneration and repair; clinical trials; blood analysis services; gene therapy research; information, advisory and consultancy services in relation to all of the aforesaid services.
Regenerative medicine services; medical services; stem cell therapy services; cell therapy services; cell therapy services for vascular regeneration and repair; cell therapy services relating to the generation of human vascular reparative cells; cell therapy services relating to the injecting, grafting or implanting of cells into patients; medical services relating to the removal, treatment and processing of cells; medical services relating to the removal, treatment and processing of stem cells; stem cell storage; human cell storage; cultured cell bank services for medical transplantation; medical laboratory services for the analysis of samples taken from patients; medical analysis services; services for the testing of blood; medical services relating to the removal, treatment and processing of human blood; information, advisory and consultancy services in relation to all of the aforesaid services.
Pharmaceuticals; drugs for medical purposes; stem cells; pharmaceutical preparations containing stem cells; stem cells for medical purposes; cells for medical use; cell growth media for growing cells for medical use; living cells for medical use; cellular function activating agents for medical purposes; vaccines, reagents for medical use; medical diagnostic reagents; biological tissue cultures for medical purposes; human allograft tissue; tissues for medical use; vascular grafts; sponges for healing wounds.
Medical devices; medical apparatus; medical instruments; apparatus for the regeneration of stem cells for medical purposes; medical devices and apparatus for vascular regeneration and repair; medical devices and apparatus for cell therapy; blood testing equipment; blood testing apparatus; artificial vascular grafts.
